[PDF][PDF] Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection
Background Monitoring the adaptive immune responses during the natural course of severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection provides useful …
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection provides useful …
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody
…, C Silacci, J Marcandalli, BJ Marsland, A Piralla… - Nature, 2013 - nature.com
Broadly neutralizing antibodies reactive against most and even all variants of the same viral
species have been described for influenza and HIV-1 (ref. 1 ). However, whether a …
species have been described for influenza and HIV-1 (ref. 1 ). However, whether a …
[HTML][HTML] Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020
…, S Roda, TC Pieri, P Valsecchi, A Piralla… - …, 2020 - eurosurveillance.org
We describe clinical characteristics, treatments and outcomes of 44 Caucasian patients with
coronavirus disease (COVID-19) at a single hospital in Pavia, Italy, from 21–28 February …
coronavirus disease (COVID-19) at a single hospital in Pavia, Italy, from 21–28 February …
[HTML][HTML] Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice
Neutralizing antibodies that target the receptor-binding domain (RBD) of the SARS-CoV-2
spike protein are among the most promising approaches against COVID-19 1 , 2 . A bispecific …
spike protein are among the most promising approaches against COVID-19 1 , 2 . A bispecific …
[HTML][HTML] Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in∼ 40% of patients
…, D Cereda, C Marrocu, A Piralla… - Journal of Experimental …, 2023 - rupress.org
Mosquito-borne West Nile virus (WNV) infection is benign in most individuals but can cause
encephalitis in <1% of infected individuals. We show that ∼35% of patients hospitalized for …
encephalitis in <1% of infected individuals. We show that ∼35% of patients hospitalized for …
[HTML][HTML] Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
F Zuo, H Abolhassani, L Du, A Piralla… - Nature …, 2022 - nature.com
The recent emergence of the Omicron variant has raised concerns on vaccine efficacy and
the urgent need to study more efficient vaccination strategies. Here we observed that an …
the urgent need to study more efficient vaccination strategies. Here we observed that an …
[HTML][HTML] Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
Background The COVID-19 pandemic is caused by the betacoronavirus SARS-CoV-2. In
November 2021, the Omicron variant was discovered and immediately classified as a variant of …
November 2021, the Omicron variant was discovered and immediately classified as a variant of …
[HTML][HTML] Recommendations for enterovirus diagnostics and characterisation within and beyond Europe
…, T Madsen, J Paul, C Moore, K von Eije, A Piralla… - Journal of clinical …, 2018 - Elsevier
Enteroviruses (EV) can cause severe neurological and respiratory infections, and occasionally
lead to devastating outbreaks as previously demonstrated with EV-A71 and EV-D68 in …
lead to devastating outbreaks as previously demonstrated with EV-A71 and EV-D68 in …
[HTML][HTML] Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy
C Alteri, V Cento, A Piralla, V Costabile… - Nature …, 2021 - nature.com
From February to April 2020, Lombardy (Italy) reported the highest numbers of SARS-CoV-2
cases worldwide. By analyzing 346 whole SARS-CoV-2 genomes, we demonstrate the …
cases worldwide. By analyzing 346 whole SARS-CoV-2 genomes, we demonstrate the …
[HTML][HTML] SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers
…, S Paolucci, E Percivalle, A Sarasini, A Piralla… - Nature …, 2021 - nature.com
Vaccine breakthrough SARS-CoV-2 infection has been monitored in 3720 healthcare workers
receiving 2 doses of BNT162b2. SARS-CoV-2 infection is detected in 33 subjects, with a …
receiving 2 doses of BNT162b2. SARS-CoV-2 infection is detected in 33 subjects, with a …
